ClearSign Technologies suspends ATM prospectus supplement for $10.39 million common stock offering; no shares sold

ClearSign Technologies Corp

On May 26, 2026, ClearSign notified H.C. Wainwright of suspension and termination of the ATM prospectus supplement filed July 17, 2025.
The ATM program allowed sale of up to $10.39 million in common stock, but no shares were sold before suspension.
The ATM Agreement remains in effect, but no sales will occur until a new prospectus supplement is filed.
Termination relates to shelf registration statement Form S-3 (File No. 333-288736) effective July 28, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.